N@N

Vincent Andrews Reiterated (CC) at Hold and Held Target at $33 on, Jul 19th, 2023

Vincent Andrews of Morgan Stanley, Reiterated "The Chemours Company" (CC) at Hold and Held Target at $33 on, Jul 19th, 2023.

Vincent has made no other calls on CC in the last 4 months.

There are 7 other peers that have a rating on CC. Out of the 7 peers that are also analyzing CC, 4 agree with Vincent's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Michael Leithead of "Barclays" Maintained at Hold with Increased Target to $40 on, Tuesday, July 11th, 2023
• Matthew DeYoe of "B of A Securities" Downgraded from Strong Buy to Hold and Decreased Target to $37 on, Thursday, June 22nd, 2023
• Arun Viswanathan of "RBC Capital" Maintained at Hold with Increased Target to $37 on, Friday, June 9th, 2023
• Jeffrey Zekauskas of "JP Morgan" Maintained at Hold with Decreased Target to $30 on, Wednesday, May 31st, 2023

These are the ratings of the 3 analyists that currently disagree with Vincent

---

• Joshua Spector of "UBS" Maintained at Strong Buy with Increased Target to $43 on, Tuesday, June 13th, 2023
• John McNulty of "BMO Capital" Maintained at Buy with Increased Target to $64 on, Monday, June 5th, 2023
• John Roberts of "Credit Suisse" Maintained at Sell with Decreased Target to $25 on, Friday, April 28th, 2023

Contributing Sources

---